Excited to present at @ASHPOfficial’s ASHP Advantage virtual symposium on the latest updates in pneumococcal disease and vaccinations. Register and get details: ashp.org/pneumococcal #ASHP25
What an amazing conference. Thanks to all my pediatric ID/ASP colleagues for continuing to remind me that I chose the right speciality and inspiring me to be better. #pidsasp24
6
151
Sarah Parsons Pharm.D., BCPPS retweeted
Ask your House representative to sign a letter in support of authorizing the PASTEUR Act, a bill that would confront the AMR crisis and spur antibiotic development. idsociety.quorum.us/campaign…
Sarah Parsons Pharm.D., BCPPS retweeted
The approval of the antifungal, isavuconazonium sulfate (Cresemba), is indicated for children as young as 1 year of age and the approval was based from 2 clinical trials. @AstellasUS
contagionlive.com/view/fda-a…
Check out our new publication on use of rifabutin and CFTR modulators for MAC in CF.
cysticfibrosisjournal.com/ar…
95
Excited to present at @ASHPOfficial’s ASHP Advantage Midyear midday symposium on an update of the pharmacist’s role in current COVID-19 prevention and treatment strategies.
@mmPharmD @yangkath
Register and get details: ashp.org/products-and-servic… #ASHP23
Sarah Parsons Pharm.D., BCPPS retweeted
Heading to @ASHPOfficial #ASHP23? Come see us Tuesday at the midday symposia presenting on COVID-19 prevention/treatment updates in immunocompromised patients. @yangkath
Can't be there live? Register for the webinar option! ashp.org/products-and-servic…
Sarah Parsons Pharm.D., BCPPS retweeted
The more powerful tool isn't always the better choice
It may create collateral damage instead of advantage
Antibiotics are the same
E.g. MSSA
➡️Vancomycin is worse than β-lactams
➡️Even among β-lactams, ceftriaxone is worse than cefazolin or ASP
#WAAW2023
NACFC was an amazing experience and I learned so much! Thank you to our program chairs for organizing the session and granting me the opportunity to collaborate with such brilliant co-presenters. ❤️
136
Come say hi. Friday at 7:15…when I present my section ..discussing alternative treatment regimens for the treatment of Mycobacterium avium complex infections in patients receiving concomitant CFTR) modulator therapy.
1
2
646
Sarah Parsons Pharm.D., BCPPS retweeted
Looking to Cover Confidently? Check out this week’s KASIC pearl to Know your Antibiotic: Ceftazidime’s Coverage Conundrum bit.ly/3OIISxl #IDtwitter #AntimicrobialResistance #antimicrobialstewardship
FDA Approves New Drug to Prevent RSV in Babies and Toddlers | FDA fda.gov/news-events/press-an…
1
121
Sarah Parsons Pharm.D., BCPPS retweeted
🆕 Episode of #Breakpoints
Drs. @zacroBID, Alison Dittmer, and @DrMichaelPulia join Dr. @thejillianhayes to discuss the ins and outs of #antimicrobialstewardship in one of the busiest parts of the hospital: the emergency department!
🎧 Listen now: sidp.pinecast.co/
Sarah Parsons Pharm.D., BCPPS retweeted
"cns penetration" may not mean what we think it means, serotonin syndrome is super rare, and please treat RMSF with doxy. this was really fun to write, thanks to an amazing team @JGPharmD @IDPharmacist @The_Real_LDA @tmjones6 @aprildyerid @ShaeferSpires
academic.oup.com/cid/advance…
IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections idsociety.org/practice-guide…
1
4
380























